Hosted on MSN1mon
FDA approves 'ketamine' nasal spray for depression — here's everything you need to knowNow, the new FDA approval means that patients will be able use the ketamine-derived nasal spray, which is marketed under the brand name Spravato ... drug's manufacturer, Janssen Pharmaceuticals ...
The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...
NICE has rejected regular NHS funding for Janssen’s depression spray Spravato ... and other factors. Spravato is approved as an adjunctive therapy administered by a nasal spray and is based ...
Stella Mental Health in Westmont specializes in medication management, Spravato (esketamine) nasal spray, transcranial magnetic stimulation (TMS), ketamine infusion therapy, stellate ganglion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results